As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...

Jubilant Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Daniel J. O'Connor as President & Chief ...

Natera Inc., a cell-free DNA and precision medicine company, has acquired Foresight Diagnostics, a leader in ultrasensitive ...

The FDA has approved BMS’ Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed CAR T cell therapy, for adults with ...

Neurimmune has expanded its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, an AstraZeneca company ...

CDMOs have become structural pillars of drug development, keeping pipelines moving, absorbing operational shocks, and turning ...

Vetter, a globally leading CDMO, announced the retirement of its Managing Director, Thomas Otto, after over 35 years at the ...

Add capabilities in Europe and the U.S. for enhanced third-party logistics to support specialty pharmaceuticals.

Designed to improve analytical capabilities by separating particles prior to analysis, enabling high-resolution ...

Rentschler Biopharma, a global CDMO, and Coriolis Pharma, a global contract research and development organization, have ...

Thermo Fisher Scientific is expanding its bioprocessing capabilities across Asia with a new Bioprocess Design Center in ...

System features “card-to-card” technology with cardboard blister and backing comprised of the same material.